2015
DOI: 10.3389/fimmu.2015.00273
|View full text |Cite
|
Sign up to set email alerts
|

Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model

Abstract: Schistosomiasis remains a major cause of morbidity in the world. The challenge today is not so much in the clinical management of individual patients, but rather in population-based control of transmission in endemic areas. Despite recent large-scale efforts, such as integrated control programs aimed at limiting schistosomiasis by improving education and sanitation, molluscicide treatment programs and chemotherapy with praziquantel, there has only been limited success. There is an urgent need for complementary… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 71 publications
(69 reference statements)
0
17
0
Order By: Relevance
“…mansoni attempted to counteract the infection‐induced hyporesponsiveness by eliciting strong type 1‐biased immune responses, via experimental host immunization with parasite tegument‐associated or ESP molecules in a plasmid cDNA construct or in conjunction with type 1 adjuvants. The resultant protection was consistently limited . We have proposed that the S .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…mansoni attempted to counteract the infection‐induced hyporesponsiveness by eliciting strong type 1‐biased immune responses, via experimental host immunization with parasite tegument‐associated or ESP molecules in a plasmid cDNA construct or in conjunction with type 1 adjuvants. The resultant protection was consistently limited . We have proposed that the S .…”
Section: Introductionmentioning
confidence: 99%
“…Vaccination against challenge S. mansoni attempted to counteract the infection-induced hyporesponsiveness by eliciting strong type 1-biased immune responses, via experimental host immunization with parasite tegumentassociated or ESP molecules in a plasmid cDNA construct or in conjunction with type 1 adjuvants. The resultant protection was consistently limited [26,27]. We have proposed that the S. mansoni -induced immunologic stalemate should be deviated towards a preponderant type 2, not type 1, immune phenotype, in an aim to recruit, engage, and activate basophils and eosinophils, the mightiest immune effectors in the chase of developing larvae in the dermis, lung capillaries and liver sinusoids.…”
Section: Introductionmentioning
confidence: 99%
“…antioxidants, anti-inflammatory agents) [15][16][17][18] into improved outcomes of critically ill patients. This issue has gradually been overcome with mandatory antioxidant vaccination programs [19] and the correction of mitochondrial damage on location by emergency medical services [20], allowing intensive care medicine to focus on supportive care rather than late "metabolic and immune damage control".…”
Section: "Prediction Is Very Difficult Especially About the Future" mentioning
confidence: 99%
“…Many reports reveal the role of antioxidants as vaccines or ameliorating vaccine-induced adverse effects. Fruits and vegetable are rich in vitamins, and hence intake of adequate amount of these food items by the pediatric population at the period of vaccination is advisable [4][5][6][7][8][9].…”
mentioning
confidence: 99%